Cargando…

Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments

BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackeprang, P.-H., Vuong, D., Volken, W., Henzen, D., Schmidhalter, D., Malthaner, M., Mueller, S., Frei, D., Kilby, W., Aebersold, D. M., Fix, M. K., Manser, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/
https://www.ncbi.nlm.nih.gov/pubmed/31533746
http://dx.doi.org/10.1186/s13014-019-1370-5
_version_ 1783452689899716608
author Mackeprang, P.-H.
Vuong, D.
Volken, W.
Henzen, D.
Schmidhalter, D.
Malthaner, M.
Mueller, S.
Frei, D.
Kilby, W.
Aebersold, D. M.
Fix, M. K.
Manser, P.
author_facet Mackeprang, P.-H.
Vuong, D.
Volken, W.
Henzen, D.
Schmidhalter, D.
Malthaner, M.
Mueller, S.
Frei, D.
Kilby, W.
Aebersold, D. M.
Fix, M. K.
Manser, P.
author_sort Mackeprang, P.-H.
collection PubMed
description BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife treatment planning system (Precision MC). METHODS: The benchmark included dose profiles in water in 15 mm depth and depth dose curves of rectangular MLC shaped fields ranging from 7.6 mm × 7.7 mm to 115.0 mm  × 100.1 mm, which were compared between IDC, Precision MC and measurements in terms of dose difference and distance to agreement. Dose distributions of three phantom cases and seven clinical lung cases were calculated using both IDC and Precision MC. The lung PTVs ranged from 14 cm(3) to 93 cm(3). Quantitative comparison of these dose distributions was performed using dose-volume parameters and 3D gamma analysis with 2% global dose difference and 1 mm distance criteria and a global 10% dose threshold. Time to calculate dose distributions was recorded and efficiency was assessed. RESULTS: Absolute dose profiles in 15 mm depth in water showed agreement between Precision MC and IDC within 3.1% or 1 mm. Depth dose curves agreed within 2.3% / 1 mm. For the phantom and clinical lung cases, mean PTV doses differed from − 1.0 to + 2.3% between IDC and Precision MC and gamma passing rates were > =98.1% for all multiple beam treatment plans. For the lung cases, lung V20 agreed within ±1.5%. Calculation times ranged from 2.2 min (for 39 cm(3) PTV at 1.0 × 1.0 × 2.5 mm(3) native CT resolution) to 8.1 min (93 cm(3) at 1.1 × 1.1 × 1.0 mm(3)), at 2% uncertainty for Precision MC for the 7 examined lung cases and 4–6 h for IDC, which, however, is not optimized for efficiency but used as a gold standard for accuracy. CONCLUSIONS: Both accuracy and efficiency of Precision MC in the context of MLC based planning for the CyberKnife M6 system were benchmarked against MC based IDC framework. Precision MC is used in clinical practice at our institute.
format Online
Article
Text
id pubmed-6751815
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67518152019-09-23 Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments Mackeprang, P.-H. Vuong, D. Volken, W. Henzen, D. Schmidhalter, D. Malthaner, M. Mueller, S. Frei, D. Kilby, W. Aebersold, D. M. Fix, M. K. Manser, P. Radiat Oncol Research BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife treatment planning system (Precision MC). METHODS: The benchmark included dose profiles in water in 15 mm depth and depth dose curves of rectangular MLC shaped fields ranging from 7.6 mm × 7.7 mm to 115.0 mm  × 100.1 mm, which were compared between IDC, Precision MC and measurements in terms of dose difference and distance to agreement. Dose distributions of three phantom cases and seven clinical lung cases were calculated using both IDC and Precision MC. The lung PTVs ranged from 14 cm(3) to 93 cm(3). Quantitative comparison of these dose distributions was performed using dose-volume parameters and 3D gamma analysis with 2% global dose difference and 1 mm distance criteria and a global 10% dose threshold. Time to calculate dose distributions was recorded and efficiency was assessed. RESULTS: Absolute dose profiles in 15 mm depth in water showed agreement between Precision MC and IDC within 3.1% or 1 mm. Depth dose curves agreed within 2.3% / 1 mm. For the phantom and clinical lung cases, mean PTV doses differed from − 1.0 to + 2.3% between IDC and Precision MC and gamma passing rates were > =98.1% for all multiple beam treatment plans. For the lung cases, lung V20 agreed within ±1.5%. Calculation times ranged from 2.2 min (for 39 cm(3) PTV at 1.0 × 1.0 × 2.5 mm(3) native CT resolution) to 8.1 min (93 cm(3) at 1.1 × 1.1 × 1.0 mm(3)), at 2% uncertainty for Precision MC for the 7 examined lung cases and 4–6 h for IDC, which, however, is not optimized for efficiency but used as a gold standard for accuracy. CONCLUSIONS: Both accuracy and efficiency of Precision MC in the context of MLC based planning for the CyberKnife M6 system were benchmarked against MC based IDC framework. Precision MC is used in clinical practice at our institute. BioMed Central 2019-09-18 /pmc/articles/PMC6751815/ /pubmed/31533746 http://dx.doi.org/10.1186/s13014-019-1370-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mackeprang, P.-H.
Vuong, D.
Volken, W.
Henzen, D.
Schmidhalter, D.
Malthaner, M.
Mueller, S.
Frei, D.
Kilby, W.
Aebersold, D. M.
Fix, M. K.
Manser, P.
Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title_full Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title_fullStr Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title_full_unstemmed Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title_short Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
title_sort benchmarking monte-carlo dose calculation for mlc cyberknife treatments
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/
https://www.ncbi.nlm.nih.gov/pubmed/31533746
http://dx.doi.org/10.1186/s13014-019-1370-5
work_keys_str_mv AT mackeprangph benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT vuongd benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT volkenw benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT henzend benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT schmidhalterd benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT malthanerm benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT muellers benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT freid benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT kilbyw benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT aebersolddm benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT fixmk benchmarkingmontecarlodosecalculationformlccyberknifetreatments
AT manserp benchmarkingmontecarlodosecalculationformlccyberknifetreatments